Director/PDMR Shareholding
Gelion plc
('Gelion' or the 'Company')
Director/PDMR Shareholding
The Company was notified that on 12 July 2024, Michael Davie, Non-Executive Director, purchased 18,548 Ordinary Shares of 0.1p each ("Ordinary Shares") at a price of 23.25 pence per Ordinary Share.
As a result of this transaction, Michael Davie's beneficial interest in the Company is 1,051,133 Ordinary Shares representing 0.77 per cent of the Company's total voting rights.
Enquiries:
Gelion plc John Wood, CEO Amit Gupta, CFO Thomas Maschmeyer, Founder and Principal Technology Advisor
| via Alma |
Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker) | +44 207 220 0500 |
Corporate Finance Neil McDonald Seamus Fricker Fergus Sullivan
ECM Leif Powis
| |
Alma Strategic Communications (Financial PR Adviser) Justine James Hannah Campbell Will Ellis Hancock | +44 20 3405 0205 gelion@almastrategic.com |
The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Michael Davie | ||||
2. | Reason for the Notification | |||||
a) | Position/status | Non-Executive Director | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Gelion plc | ||||
b) | LEI | 2138008NC7YL3MCUDR84 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the Financial instrument, type of instrument | Ordinary shares of 0.1p each | ||||
Identification code | GB00BNBQZD59 | |||||
b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information: · Aggregated volume · Price | See above | ||||
e) | Date of the transaction | 12 July 2024 | ||||
f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.